Trial intelligence / Profile preview

Tetracycline in progressive external ophthalmoplegia

2007-005274-31Phase 2Completed

Sponsor
Azienda Ospedaliero-Universitaria Pisana
Start
Oct 2008
Modality
Small Molecules
Countries
1
01

Overview

Phase 2, single-arm trial of tetracycline in progressive external ophthalmoplegia (PEO), sponsored by Azienda Ospedaliero-Universitaria Pisana. Primary endpoint: Anaerobic lactacidemic threshold. Started Oct 2008; status: completed.

02

Drugs

tetracycline
03

Conditions

progressive external ophthalmoplegia (PEO)

Beyond the preview

Go deeper on 2007-005274-31.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2007-005274-31.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call